A Clinical Metabolite of Azidothymidine Inhibits Experimental Choroidal Neovascularization and Retinal Pigmented Epithelium Degeneration

PURPOSE: Azidothymidine (AZT), a nucleoside reverse transcriptase inhibitor, possesses anti-inflammatory and anti-angiogenic activity independent of its ability to inhibit reverse transcriptase. The aim of this study was to evaluate the efficacy of 5′-glucuronyl azidothymidine (GAZT), an antiretrovi...

Descripción completa

Detalles Bibliográficos
Autores principales: Narendran, Siddharth, Pereira, Felipe, Yerramothu, Praveen, Apicella, Ivana, Wang, Shao-bin, Varshney, Akhil, Baker, Kirstie L., Marion, Kenneth M., Ambati, Meenakshi, Ambati, Vidya L., Ambati, Kameshwari, Sadda, Srinivas R., Gelfand, Bradley D., Ambati, Jayakrishna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Association for Research in Vision and Ophthalmology 2020
Materias:
Retina
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7441363/
https://www.ncbi.nlm.nih.gov/pubmed/32749462
http://dx.doi.org/10.1167/iovs.61.10.4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7441363/
https://www.ncbi.nlm.nih.gov/pubmed/32749462
http://dx.doi.org/10.1167/iovs.61.10.4

Ejemplares similares